SCHEMBL20768136

SCHEMBL20768136

CCN(C)Cc1cc[c]cc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.47
CHRNA4 P43681 1/20 0.47
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 1/20 0.40
LTA4H P09960 1/20 0.37
HRH3 Q9Y5N1 2/20 0.37
CARM1 Q86X55 1/20 0.36
PRMT6 Q96LA8 1/20 0.36
PRMT8 Q9NR22 1/20 0.36
PYCR1 P32322 3/20 0.35
TSHR P16473 2/20 0.35
LMNA P02545 2/20 0.35
USP2 O75604 1/20 0.35
CYP3A4 P08684 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
BLM P54132 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12763726 0.83 CHRNB2 (0.56) CHRNB2CHRNA4ALDH1A1KDM4ELTA4H
SCHEMBL27816979 0.80 CARM1 (0.35) ALDH1A1KDM4EHRH3CARM1PRMT6
SCHEMBL2645780 0.80 ALDH1A1 (0.54) ALDH1A1KDM4ECARM1PRMT6PRMT8
SCHEMBL188508 0.79 HRH3 (0.60) KDM4EHRH3PYCR1TSHR
SCHEMBL18227681 0.78 MEN1 (0.47) ALDH1A1KDM4ELTA4HHRH3CARM1
SCHEMBL162718 0.78 HRH3 (0.56) CHRNB2CHRNA4ALDH1A1HRH3TSHR
SCHEMBL3038304 0.77 CARM1 (0.41) ALDH1A1KDM4ECARM1PRMT6PRMT8
SCHEMBL12910454 0.76 CHRNB2 (0.50) CHRNB2CHRNA4ALDH1A1KDM4ELTA4H
SCHEMBL355111 0.76 TSHR (0.61) CHRNB2CHRNA4ALDH1A1KDM4ECARM1
SCHEMBL27625032 0.76 HRH3 (0.54) CHRNB2CHRNA4ALDH1A1HRH3TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1393131-A Antifungal triazole compounds MILITARY MEDICAL UNIV NO 2 P L (CN) 2003-01-29 CN claimed
US-10604525-B2 Pyrazolopyrimidine derivatives BAYAL ANIMAL HEALTH GMBH (DE) 2020-03-31 US disclosed
US-20190071447-A1 PYRAZOLOPYRIMIDINE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2019-03-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10604525-B2 Pyrazolopyrimidine derivatives P2RX5, RECQL, P2RX1 CHRNB2 3776/4885CHRNA4 2589/4885ALDH1A1 1297/4885
US-20190071447-A1 PYRAZOLOPYRIMIDINE DERIVATIVES P2RX5, RECQL, P2RX1 CHRNB2 3776/4885CHRNA4 2589/4885ALDH1A1 1297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.